Navigation Links
West Pharmaceutical Services, Inc. Announces Annual Meeting Webcast

LIONVILLE, Pa., April 30 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc., (NYSE: WST) today announced that it will webcast its 2008 Annual Meeting of Shareholders. The meeting will be held on Tuesday, May 6, 2008, at 9:30 a.m. Eastern Time.

The live webcast can be accessed through the "Investor" section of West's web site at Please allow extra time prior to the live webcast to visit the site and download the streaming media software required to listen to the Internet webcast.

A replay of the webcast will be available on the site within two hours of the meeting and will remain available until May 20, 2008.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West Pharmaceutical Services supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at

Contacts: Investors and Financial Media:

West Pharmaceutical Services, Inc. Financial Dynamics

Michael A. Anderson Evan Smith / Theresa Kelleher

Vice President and Treasurer (212) 850-5600

(610) 594-3345

SOURCE West Pharmaceutical Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
2. Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
3. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
4. Agreement Executed for Amneal Pharmaceuticals to Acquire the Assets of Interpharm Holdings
5. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
6. Onyx Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
7. Antipodean Pharmaceuticals Announces Results of Phase 2 Study of Lead Compound MitoQ(R)
8. Pharma Base S.A. Launches Osamine(TM) Pharmaceutical Grade Glucosamine in North America
9. Prime Hires Rachelle Wan as Vice President of Pharmaceutical Trade Relations
10. The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future
11. Complimentary Excerpt Available from Best Practices: Pharmaceutical Competitive Intelligence Excellence - Optimizing Data Collection within Approved Guidelines
Post Your Comments:
(Date:12/1/2015)... ME (PRWEB) , ... December 01, 2015 , ... Royal ... reports a new study that found post-menopausal women who took the nutritional supplement creatine, ... than women who trained but did not take creatine. , The report is part ...
(Date:12/1/2015)... ... ... is the first health care provider in the region to offer the vBloc® Therapy ... vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients over ... to 45 kg, or a BMI of at least 35 to 39.9 kg with a ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... oncology and hematology continuing medical education (CME), today announced that the first annual ... Hyatt New York. , “The prevention, detection and treatment of gastrointestinal cancers are ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , ... that its iconic bottle has won top honors in Beverage World Magazine’s Global Packaging ... also announced that it has been selected as a 2015 U.S.A. Taste Champion in ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... there are professionals who believe that with innovative technologies and under the right ... patient to get the benefit of a dual-approach to his or her therapeutic ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015  Athletic apparel company Tommie Copper ... pay $1.35 million to settle Federal Trade Commission ... compression clothing would relieve severe and chronic pain ... Tommie Copper,s proposed settlement ... its founder and chairman Thomas Kallish ...
(Date:12/1/2015)... and PITTSBURGH , Dec. ... announced that it expects to be the first to ... funded by international donors, TLE400 (Tenofovir Disoproxyl Fumarate 300 ... for $99 per patient, per year. Mylan partnered with ... The significantly reduced price could generate savings of tens ...
(Date:12/1/2015)... Virginia , 1 de diciembre de ... en tecnología para cuchillas de precisión, develó ... programa de identidad de marca. El nuevo ... el diseño y la ingeniería de productos ... la diferencia". ...
Breaking Medicine Technology: